BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1769131)

  • 1. Effects of ambient glycaemic state on growth hormone responsiveness in insulin-dependent diabetes.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):499-504. PubMed ID: 1769131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise-induced growth hormone response in euglycaemia and hyperglycaemia in patients with Type 1 diabetes mellitus.
    Jenni S; Christ ER; Stettler C
    Diabet Med; 2010 Feb; 27(2):230-3. PubMed ID: 20546269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a central abnormality in the regulation of growth hormone secretion in insulin-dependent diabetes.
    Sharp PS; Foley K; Kohner EM
    Diabet Med; 1984 Sep; 1(3):205-8. PubMed ID: 6242799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the somatostatin analogue octreotide on growth hormone secretion in insulin-dependent diabetics without residual insulin secretion.
    Wurzburger MI; Prelevic GM; Sonksen PH; Balint-Peric LA
    Horm Metab Res; 1992 Jul; 24(7):329-32. PubMed ID: 1516889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.
    Mullis PE; Pal BR; Matthews DR; Hindmarsh PC; Phillips PE; Dunger DB
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):255-63. PubMed ID: 1348664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of improved blood glucose on growth hormone and cortisol secretion in insulin-dependent diabetes mellitus.
    Würzburger MI; Prelevic GM; Sönksen PH; Peric LA; Till S; Morris RW
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):787-97. PubMed ID: 2200623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
    Cheetham TD; Clayton KL; Taylor AM; Holly J; Matthews DR; Dunger DB
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):515-22. PubMed ID: 8187319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
    Pal BR; Matthews DR; Edge JA; Mullis PE; Hindmarsh PC; Dunger DB
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):93-100. PubMed ID: 8435890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus--a prospective single-blinded randomised crossover trial.
    Jenni S; Oetliker C; Allemann S; Ith M; Tappy L; Wuerth S; Egger A; Boesch C; Schneiter P; Diem P; Christ E; Stettler C
    Diabetologia; 2008 Aug; 51(8):1457-65. PubMed ID: 18512043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
    Wurzburger MI; Prelevic GM; Sönksen PH; Balint-Peric LA; Wheeler M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):267-72. PubMed ID: 8325951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation and neuroregulatory control of growth hormone secretion.
    Ogilvy-Stuart AL; Wallace WH; Shalet SM
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects.
    Valcavi R; Zini M; Davoli S; Portioli I
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):360-4. PubMed ID: 1483293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of prolonged bromocriptine administration on PRL secretion GH and glycaemic control in stable insulin-dependent diabetes mellitus.
    Scobie IN; Kesson CM; Ratcliffe JG; Maccuish AC
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):179-85. PubMed ID: 6342861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.